🔎 Trials Near Me

Pradžia › Didelis depresinis sutrikimas › Kalifornija

Didelis depresinis sutrikimas klinikiniai tyrimai Kalifornija

52 tyrimai dėl Didelis depresinis sutrikimas ieško dalyvių vietose Kalifornija.

Miestai Kalifornija

Oficialus tyrimo tekstas (anglų kalba)

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  • Irvine Clinical Research, Irvine
  • Healthy Brain Clinic, Long Beach
  • Oakland Clinical, Oakland
  • ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07775300

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

  • CI Trials, Bellflower
  • Behavioral Research Specialists LLC, Glendale
  • Excell Research Inc, Oceanside
  • ir dar 3
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  • PAMOJA Clinical Institute LLC, Anaheim
  • Axiom Research, Colton
  • Behavioral Research Specialists LLC, Glendale
  • ir dar 3
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

  • Buena Park Research Center, Buena Park
  • Inland Psychiatric Medical Group, Inc. - Chino, Chino
  • Synergy Research - San Diego, Lemon Grove
  • ir dar 3
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07621237

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  • CNRI-Los Angeles, LLC, Pico Rivera
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT05850689

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • Behavioral Research Specialists, LLC, Glendale
  • CalNeuro Research Group, Los Angeles
  • Lipov Medical Group, Los Angeles
  • ir dar 4
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06793397

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

  • Vanda Investigational Site, Garden Grove
  • Vanda Investigational Site, Orange
  • Vanda Investigational Site, Redlands
  • ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06830044

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Chino
  • Neurocrine Clinical Site, Fresno
  • Neurocrine Clinical Site, Long Beach
  • ir dar 3
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07105111

Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study

  • UCSD Interventional Psychiatry, San Diego
Renkami dalyviai
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07217223

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Chino
  • Seaport Investigator Site, Garden Grove
  • Seaport Investigator Site, Glendale
  • ir dar 2
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-14 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

  • Inland Psychiatric Medical Group, Chino
  • Behavioral Research Specialists, LLC, Glendale
  • Kadima Neuropsychiatry Institute, La Jolla
  • ir dar 1
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-14 · NCT07284667

Near Infrared Spectroscopy (NIRS) for Assessment of Depression

  • San Francisco Veterans Affairs Medical Center, San Francisco
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT04061148

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Clinical Innovations Inc, Bellflower
  • Center for Neurohealth, La Jolla
  • Artemis Institute for Clinical Research, San Diego
  • ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Bellflower
  • Draig Clinical Site, Costa Mesa
  • Draig Clinical Site, Lafayette
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

  • USC University Hospital, Los Angeles
  • UCLA Department of Psychiatry, Los Angeles
  • University of California at Davis, Sacramento
Renkami dalyviai
Amžius nuo 22 iki 70 · Visoms lytims · Atnaujinta 2026-08-28 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

  • Draig Clinical Site, Oceanside
  • Draig Clinical Site, San Diego
  • Draig Clinical Site, Torrance
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-26 · NCT07300969

Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression

  • Stanford University, Stanford
Renkami dalyviai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2026-08-21 · NCT07188623

Enhancing Veteran-Clinical Collaboration in VA PRRCs

  • VA San Diego Healthcare System, San Diego, CA, San Diego
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT06898879

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Glendale
  • Neurocrine Clinical Site, Redlands
  • Neurocrine Clinical Site, San Francisco
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT06911112

Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS

  • Stanford Hospital, Stanford
Renkami dalyviai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-11 · NCT04870255

Pain and Major Depressive Disorder

  • UCLA Semel Institute, Los Angeles
Renkami dalyviaiNurodytas atlygis dalyviams
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-11 · NCT04556890

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

  • ATP Clinical Research Orange County, Orange
  • Kadima Neuropsychiatry Institute, San Diego
  • UCSF Department of Neurology, San Francisco
  • ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07592689

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Chino
  • Neurocrine Clinical Site, Los Angeles
  • Neurocrine Clinical Site, Stanford
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-10 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Accellacare - Moorpark, Moorpark
  • ATP Clinical Research, Orange
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-06 · NCT07412756

Closed-Loop Deep Brain Stimulation for Major Depression

  • University of California, San Francisco, San Francisco
Renkami dalyviai
Amžius nuo 22 iki 70 · Visoms lytims · Atnaujinta 2026-08-03 · NCT04004169

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Behavioral Research Specialists, Llc, Glendale
  • Irvine Clinical Research, Irvine
  • CalNeuro Research Group, Inc., Los Angeles
  • ir dar 6
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  • Irvine Clinical Research, Irvine
  • CalNeuro Research Group, Los Angeles
  • Sunwise Clinical Research LLC, Walnut Creek
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06547489

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  • Catalina Research Institute, LLC, Montclair
  • Excell Research, Inc, Oceanside
  • Anderson Clinical Research, Redlands
  • ir dar 3
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-07-27 · NCT07115329

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Oceanside
  • Neurocrine Clinical Site, Orange
  • Neurocrine Clinical Site, San Jose
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-24 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Glendale
  • Neurocrine Clinical Site, Los Angeles
  • Neurocrine Clinical Site, Oceanside
  • ir dar 5
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-24 · NCT06966401

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

  • Clinical Research Site, Bellflower
  • Clinical Research Site, Chino
  • Clinical Research Site, Glendale
  • ir dar 7
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-24 · NCT07484217

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

  • Acacia Clinics, Sunnyvale
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-16 · NCT06376734

Sleep TMS for Depression

  • Stanford University, Stanford
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-23 · NCT06824415

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

  • Advanced Research Center /ID# 277537, Anaheim
  • Sun Valley Research Center /ID# 277513, Imperial
  • Synergy San Diego /ID# 277553, Lemon Grove
  • ir dar 4
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-15 · NCT07276997

Evaluating tDCS Brain-stimulation in Depression Using MRI

  • University of California Los Angeles (UCLA), Los Angeles
Renkami dalyviai
Amžius nuo 20 iki 55 · Visoms lytims · Atnaujinta 2026-06-08 · NCT05598034

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • CenExel, Garden Grove
  • Behavioral Research Specialists, LLC, Glendale
  • Kadima Neuropsychiatry Institute, La Jolla
  • ir dar 2
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-11 · NCT06524830

Mindfulness Engaged Neurostimulation for Depression (MEND II)

  • UC San Diego Health Psychiatry, San Diego
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-06 · NCT07512284

Regulation of Affect and Physiology in Depression

  • University of Southern California, Los Angeles
Renkami dalyviai2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 27 · Visoms lytims · Atnaujinta 2026-05-04 · NCT06345859

Maintenance rTMS for Depression (Maitr-De)

  • University of California, San Diego, San Diego
Renkami dalyviai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-04-29 · NCT06938841

ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1

  • Salma Health, La Jolla
  • Salma Health, Laguna Hills
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-14 · NCT07528014

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.